Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
HIMS

HIMS - Hims & Hers Health, Inc. Stock Price, Fair Value and News

$28.67-1.01 (-3.40%)
Market Closed

79/100

HIMS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

79/100

HIMS

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$43.07

Target 3M

$32.52

Target 6M

$35.72

HIMS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HIMS Price Action

Last 7 days

-0.8%

Last 30 days

-15.9%

Last 90 days

-34.9%

Trailing 12 Months

-9.1%

HIMS RSI Chart

HIMS Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

HIMS Valuation

Market Cap

6.4B

Price/Earnings (Trailing)

48.06

Price/Sales (Trailing)

2.91

EV/EBITDA

41.42

Price/Free Cashflow

19.78

HIMS Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$43.07

Target 3M

$32.52

Target 6M

$35.72

HIMS Fundamentals

HIMS Revenue

Revenue (TTM)

2.2B

Rev. Growth (Yr)

49.16%

Rev. Growth (Qtr)

9.94%

HIMS Earnings

Earnings (TTM)

133.8M

Earnings Growth (Yr)

-79.13%

Earnings Growth (Qtr)

-62.89%

HIMS Profitability

Operating Margin

75.01%

EBT Margin

5.78%

Return on Equity

23.03%

Return on Assets

5.99%

Free Cashflow Yield

5.06%

HIMS Investor Care

Shares Dilution (1Y)

4.35%

Diluted EPS (TTM)

0.53

HIMS Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20251.8B2.0B2.2B0
2024959.4M1.1B1.2B1.5B
2023616.4M710.7M792.6M872.0M
2022320.9M373.7M444.4M526.9M
2021171.0M195.8M228.6M271.9M
202099.1M115.7M132.2M148.8M
201900082.6M
Get all data in R, Python etc through our Historical Stock Data APIs

About Hims & Hers Health, Inc.

HIMS
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
 CEO
 WEBSITEforhims.com
 SECTORConsumer Defensive
 INDUSTRYHousehold & Personal Products
 EMPLOYEES651

Hims & Hers Health, Inc. Frequently Asked Questions

HIMS is the stock ticker symbol of Hims & Hers Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Hims & Hers Health, Inc. is 6.43 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check HIMS's fair value in chart for subscribers.

The fair value guage provides a quick view whether HIMS is over valued or under valued. Whether Hims & Hers Health, Inc. is cheap or expensive depends on the assumptions which impact Hims & Hers Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HIMS.

As of Wed Jan 28 2026, HIMS's PE ratio (Price to Earnings) is 48.06 and Price to Sales (PS) ratio is 2.91. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HIMS PE ratio will change depending on the future growth rate expectations of investors.